L1 Health and Blantyre Capital Acquire Remedica and Sun Wave Pharma
October 21, 2021
L1 Health and Blantyre Capital have acquired European pharmaceutical businesses Remedica (Cyprus) and Sun Wave Pharma (Romania) as part of a debt-for-assets restructuring with Johannesburg-listed Ascendis Health; the deal closed on October 21. Remedica is a generics manufacturer with production and distribution across 160 countries, while Sun Wave Pharma is a leading nutraceuticals/nutritional-products provider in Eastern Europe.
- Buyers
- L1 Health, Blantyre Capital
- Targets
- Remedica, Sun Wave Pharma
- Sellers
- Ascendis Health
- Industry
- Pharmaceuticals
- Location
- Cyprus
- Transaction Type
- Divestiture
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.